Amoy Diagnostics Co Ltd (300685) — Capital Reinvestment Ratio
Amoy Diagnostics Co Ltd (300685) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥110.87 Million) in capital expenditures (CN¥25.34 Million). See 300685 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Amoy Diagnostics Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Amoy Diagnostics Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Check Amoy Diagnostics Co Ltd (300685) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Amoy Diagnostics Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Amoy Diagnostics Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see how much is Amoy Diagnostics Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.12x | CN¥341.85 Million | CN¥40.21 Million | ▼ -21.7% |
| 2023 | 0.15x | CN¥298.72 Million | CN¥44.87 Million | ▼ -71.4% |
| 2022 | 0.53x | CN¥149.04 Million | CN¥78.29 Million | ▲ +18.5% |
| 2021 | 0.44x | CN¥168.16 Million | CN¥74.55 Million | ▲ +69.0% |
| 2020 | 0.26x | CN¥220.69 Million | CN¥57.89 Million | ▲ +70.5% |
| 2019 | 0.15x | CN¥151.52 Million | CN¥23.31 Million | ▼ -63.1% |
| 2018 | 0.42x | CN¥93.45 Million | CN¥38.97 Million | ▲ +76.8% |
| 2017 | 0.24x | CN¥91.89 Million | CN¥21.68 Million | ▼ -83.3% |
| 2016 | 1.42x | CN¥32.18 Million | CN¥45.60 Million | ▼ -9.2% |
| 2015 | 1.56x | CN¥19.10 Million | CN¥29.79 Million | ▼ -47.0% |
| 2014 | 2.94x | CN¥15.69 Million | CN¥46.20 Million | ▼ -25.6% |
| 2013 | 3.96x | CN¥8.56 Million | CN¥33.88 Million | — |